Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves
- PMID: 33928804
- PMCID: PMC8114316
- DOI: 10.1177/23247096211013215
Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves
Abstract
Bronchopleural fistula (BPF) is associated with high morbidity if left untreated. Although rare, the frequency of BPF in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is becoming recognized in medical literature. We present a case of a 64-year-old male with BPF with persistent air leak due to SARS-CoV-2 pneumonia treated with Spiration Valve System endobronchial valve (EBV). An EBV was placed in the right middle lobe with successful cessation of air leak. In conclusion, the use of EBVs for BPF with persistent air leaks in SARS-CoV-2 patients who are poor surgical candidates is effective and safe.
Keywords: COVID-19; bronchopleural fistula; endobronchial valve; interventional pulmonology.
Conflict of interest statement
Figures
References
- 
    - Wright CD, Wain JC, Mathisen DJ, Grillo HC. Postpneumonectomy bronchopleural fistula after sutured bronchial closure: incidence, risk factors, and management. J Thorac Cardiovasc Surg. 1996;112:1367-1371. - PubMed
 
- 
    - Salik I, Vashisht R, Abramowicz AE. Bronchopleural Fistula. StatPearls; 2021. - PubMed
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Miscellaneous
 
         
               
              